Plasma-Derived Therapies (PDT)

Transform the lives of patients through innovation and sustainability from plasma donation to delivery of medicines.

Plasma is a vital natural resource used to create lifesaving and life-sustaining therapies that hundreds of thousands of people around the world rely on every day.4,5 For many, especially those who are immune-compromised, plasma-derived therapies are their only treatment option.

While there have been advancements in plasma-derived medicine in the last 80+ years, there remains significant untapped therapeutic potential in plasma. Through transformative R&D, we are reimagining plasma-derived therapies for patients and changing what it means to live with rare and complex, chronic diseases.

Our PDT R&D organization is focused on delivering transformative solutions where we can make the greatest impact – continually asking ourselves:

• How can we do more for people who rely on plasma-derived therapies today?
• How can we harness the power in plasma to help more people in the future?

Dedicated to the collection of plasma that enables the production of vital lifesaving and life-sustaining therapies to treat rare and chronic complex diseases, BioLife Plasma Services offers one of the most innovative plasma donation networks in the world.

Operating from ~200 state-of-the-art facilities throughout the U.S. and Europe, we build strong relationships, essential connections, and long-term partnerships to offer the best possible donation experience – providing more people than ever with the opportunity to change and save lives.

As we continue to grow and modernize our operations, our 8,000+ employees – including trained medical staff and dedicated quality and regulatory experts – continue to set new standards for donation to responsibly and sustainably deliver better health for people and a brighter future for the world.

Explore Biolife